These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20053640)

  • 1. ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).
    Olafsen T; Sirk SJ; Betting DJ; Kenanova VE; Bauer KB; Ladno W; Raubitschek AA; Timmerman JM; Wu AM
    Protein Eng Des Sel; 2010 Apr; 23(4):243-9. PubMed ID: 20053640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.
    Olafsen T; Betting D; Kenanova VE; Salazar FB; Clarke P; Said J; Raubitschek AA; Timmerman JM; Wu AM
    J Nucl Med; 2009 Sep; 50(9):1500-8. PubMed ID: 19690034
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zettlitz KA; Tavaré R; Tsai WK; Yamada RE; Ha NS; Collins J; van Dam RM; Timmerman JM; Wu AM
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):489-500. PubMed ID: 30456475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ImmunoPET of Malignant and Normal B Cells with
    Zettlitz KA; Tavaré R; Knowles SM; Steward KK; Timmerman JM; Wu AM
    Clin Cancer Res; 2017 Dec; 23(23):7242-7252. PubMed ID: 28928164
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with
    Yoon JT; Longtine MS; Marquez-Nostra BV; Wahl RL
    J Nucl Med; 2018 Aug; 59(8):1219-1224. PubMed ID: 29348316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments.
    Li K; Tavaré R; Zettlitz KA; Mumenthaler SM; Mallick P; Zhou Y; Marks JD; Wu AM
    Mol Cancer Ther; 2014 Nov; 13(11):2607-17. PubMed ID: 25143449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel engineered anti-CD20 tracer enables early time PET imaging in a humanized transgenic mouse model of B-cell non-Hodgkins lymphoma.
    Natarajan A; Hackel BJ; Gambhir SS
    Clin Cancer Res; 2013 Dec; 19(24):6820-9. PubMed ID: 24097872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
    Wilbur DS; Park SI; Chyan MK; Wan F; Hamlin DK; Shenoi J; Lin Y; Wilbur SM; Buchegger F; Pantelias A; Pagel JM; Press OW
    Bioconjug Chem; 2010 Jul; 21(7):1225-38. PubMed ID: 20597486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.
    White JB; Boucher DL; Zettlitz KA; Wu AM; Sutcliffe JL
    Nucl Med Biol; 2015 Dec; 42(12):945-57. PubMed ID: 26341848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers.
    Dolezal O; Pearce LA; Lawrence LJ; McCoy AJ; Hudson PJ; Kortt AA
    Protein Eng; 2000 Aug; 13(8):565-74. PubMed ID: 10964986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging.
    Olafsen T; Sirk SJ; Olma S; Shen CK; Wu AM
    Tumour Biol; 2012 Jun; 33(3):669-77. PubMed ID: 22392499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
    Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.
    Leyton JV; Olafsen T; Sherman MA; Bauer KB; Aghajanian P; Reiter RE; Wu AM
    Protein Eng Des Sel; 2009 Mar; 22(3):209-16. PubMed ID: 18957406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
    Schneider DW; Heitner T; Alicke B; Light DR; McLean K; Satozawa N; Parry G; Yoo J; Lewis JS; Parry R
    J Nucl Med; 2009 Mar; 50(3):435-43. PubMed ID: 19223400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting.
    Kortt AA; Dolezal O; Power BE; Hudson PJ
    Biomol Eng; 2001 Oct; 18(3):95-108. PubMed ID: 11566601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmunoPET Imaging of α
    White JB; Hu LY; Boucher DL; Sutcliffe JL
    Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.
    Vaidyanathan G; Jestin E; Olafsen T; Wu AM; Zalutsky MR
    Nucl Med Biol; 2009 Aug; 36(6):671-80. PubMed ID: 19647173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.